Researchers in the US and Europe are implementing pathogen sequencing surveillance programs to track infectious diseases within hospitals.
The test, which runs on the firm's Revogene molecular diagnostics instrument, has now been launched in Canada.
The test for resistance genes from carbapenemase-producing Gram-negative bacteria can now be used on perirectal swabs and pure colonies.
The approval expands the firm's product range now available to European customers.
Researchers identified and began characterizing carbapenemase-producing bacteria from wastewater samples in ICU pipes and other sites at an NIH hospital.
The BD MAX Check-Points CPO assay detects common carbapenemase-producing organisms in less than 2.5 hours.
Using MRSA isolates from England, researchers uncovered hospital-specific, community-specific, and overlapping transmission clusters.
The ASM speaker said that strains collected from two different hospital systems also exhibited overlap in their SNP and other content.
The company hopes to raise funding this summer and has been conducting pilots with NewYork-Presbyterian Hospital and Memorial Sloan Kettering Cancer Center.
The researchers analyzed DNA from more than 6,500 samples taken from patients, staff, patient rooms, nurse stations, water, and air.
Thermo Fisher Scientific says it will no longer sell DNA sequencing machines in China's Xinjiang region, according to the Wall Street Journal.
New Scientist reports that 20 percent of human and yeast proteins are uncharacterized.
The University of Zurich's Ruedi Aebersold and his colleagues analyzed a dozen HeLa cell lines to find differences in gene expression, protein levels, and more.
In Nature this week: protein-coding variants associated with body-fat distribution, and more.